Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bio-Path Holdings
Bio-Path Holdings
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
CP Wire
Mon, 08/27/18 - 10:56 pm
Bio-Path Holdings
prexigebersen
acute myeloid leukemia
clinical trials
Bio-Path Doses First Patient in Ph II Expansion Trial in Acute Myeloid Leukemia
Mon, 08/27/18 - 09:49 am
Bio-Path Holdings
prexigebersen
acute myeloid leukemia